Abstract
Normal subjects were given 0.75 mg of intravenous digoxin as a bolus and a 1-hr infusion, Radio-immunoassayed serum concentrations obtained over 48 hr and urinary excretion rates over 6 days were simultaneously fitted to a two- compartment open model by computer nonlinear least-squares regression. Serum concentration data alone were also fitted by this program. There was good agreement in calculated parameters between the two routes of administration in five of eight subjects, but the infusion mode of administration produced less variability in the apparent pharmacokinetic constants. The β half-life values obtained from serum concentration data alone (24.2 hr) underestimated the half-lives obtained by the simultaneous fit (44.1 hr). The steady-state volume of distribution of digoxin averaged 590±164 liters (±1 sd).The renal clearance of digoxin (140±41 ml/min/1.73 m 2)was significantly higher than creatinine clearance (101±13 ml/min/ 1.73 m 2),indicating tubular secretion of the drug. Digoxin body clearances were 188±44 ml/min/ 1.73 m 2,indicating elimination of 25% of the dose by nonrenal mechanisms. Urinary excretion data are essential for proper pharmacokinetic analysis of digoxin disposition and reveal a slower rate of elimination than that suggested by earlier studies which determined only serum concentrations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
J. E. Doherty, W. J. Flanigan, and G. V. Dalrymple. Tritiated digoxin. XVII. Excretion and turnover times in normal donors before and after nephrectomy and in the paired recipients of the kidney after transplantation.Am. J. Cardiol. 29: 470–474 (1972).
H. J. Gilfrich, G. Bodem, and C. A. Chidsey. Untersuchungen zur Pharmakokinetik von Digoxin.Arzneim. Forsch. 23: 1659–1660 (1974).
R. H. Reuning, R. A. Sams, and R. E. Notari. Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin.J. Clin. Pharmacol. 13: 127–141 (1973).
P. M. Bloom, W. B. Nelp, and S. H. Tuell. Relationship of the excretion of tritiated digoxin to renal function.Am. J. Med. Sci. 251: 133–144 (1966).
F. I. Marcus, A. Peterson, A. Salel, J. Scully, and G. G. Kapadia. The metabolism of tritiated digoxin in renal insufficiency in dogs and man.J. Pharmacol. Exp. Ther. 152: 372–382 (1966).
W. Shapiro, K. Harahara, and K. Taubert. Relationship of plasma digitoxin and digoxin to cardiac response following intravenous digitalization in man.Circulation 42: 1065–1072 (1970).
D. J. Greenblatt, D. W. Duhme, J. Koch-Weser, and T. W. Smith. Intravenous digoxin as a bioavailability Standard; slow infusion and rapid injection.Clin. Pharmacol. Ther. 15: 510–513 (1974).
C. M. Metzler. NONLIN: A Computer Program for Parameter Estimation in Nonlinear Situations, Upjohn Co., Kalamazoo, Mich., Technical Report No. 7292/69/7292/005, Nov. 25, 1969.
J. C. K. Loo and S. Riegelman. Assessment of pharmacokinetic constants from postinfusion blood curves obtained after IV infusion.J. Pharm. Sci. 59: 53–55 (1970).
W. J. Jusko and M. Gibaldi. Effects of change in elimination on various parameters of the two-compartment open model.J. Pharm. Sci. 61: 1270–1273 (1972).
C. I. Bliss.Statistics in Biology, Vol. 1, McGraw-Hill, New York, 1967, p. 211.
J. G. Wagner. Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy.Am. Heart. J. 88: 133–138 (1974).
R. G. Stoll, M. S. Christensen, E. Sakmar, and J. G. Wagner. The specificity of the digoxin radioimmunoassay procedure.Res. Commun. Chem. Pathol. Pharmacol. 4: 503–510 (1972).
J. R. Koup, W. J. Jusko, C. M. Elwood, and R. K. Kohli. Digoxin pharmacokinetics: Role of renal failure in dosage regimen design.Clin. Pharmacol. Ther. 17 (1975), in press.
P. R. Klink, R. I. Poust, J. L. Colaizzi, and R. H. McDonald. Bioavailability and dissolution properties of two commercial digoxin tablets.J. Pharm. Sci. 63: 1231–1234 (1974).
W. G. Kramer, R. P. Lewis, T. C. Cobb, W. F. Forester, J. A. Visconti, L. A. Wanke, H. G. Boxenbaum, and R. H. Reuning. Pharmacokinetics of digoxin: Comparison of a two- and three-compartment model in man.J. Pharmacokin. Biopharm. 2: 299–312 (1974).
E. E. Ohnhaus, P. Spring, and L. Dettli. Eliminationskinetik und Dosierung von Digoxin bei Patienten mit Niereninsuffizienz.Deutsch. Med. Wschr. 99: 1797–1803 (1974).
L. B. Sheiner, B. Rosenberg, and K. L. Melmon. Modelling of individual pharmacokinetics for computer-aided drug dosage.Comp. Biomed. Res. 5: 441–459 (1972).
E. Steiness. Renal tubular secretion of digoxin.Circulation 50: 103–107 (1974).
R. W. Jelliffe. An improved method of digoxin therapy.Ann. Int. Med. 69: 703–717 (1968).
G. A. Ewy, B. M. Groves, M. F. Ball, L. Nimmo, B. Jackson, and F. Marcus. Digoxin metabolism in obesity.Circulation 44: 810–814 (1971).
Author information
Authors and Affiliations
Additional information
Supported in part by Grant 20852 from the National Institutes of General Medical Sciences, National Institutes of Health.
Rights and permissions
About this article
Cite this article
Koup, J.R., Greenblatt, D.J., Jusko, W.J. et al. Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses. Journal of Pharmacokinetics and Biopharmaceutics 3, 181–192 (1975). https://doi.org/10.1007/BF01067907
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01067907